Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02774291
Title Anti-ESO (Cancer/Test Antigen) mTCR-transduced Autologous Peripheral Blood Lymphocytes and Combination Chemotherapy in Treating Patients With Metastatic Cancer That Expresses NY-ESO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Albert Einstein College of Medicine
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Aldesleukin

Cyclophosphamide + Fludarabine

Filgrastim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.